IntelliCyt Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 55

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $97.3M

IntelliCyt General Information

Description

Developer of cell and bead-based screening for drug discovery. The company develops high-throughput, high-content cell and bead-based screening which are used in phenotypic drug discovery, antibody discovery and in vitro toxicity testing.

Contact Information

Formerly Known As
Sage Sciences
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 9620 San Mateo Boulevard NorthEast
  • Albuquerque, NM 87113
  • United States
Primary Industry
Discovery Tools (Healthcare)
Acquirer
Vertical(s)
Corporate Office
  • 9620 San Mateo Boulevard NorthEast
  • Albuquerque, NM 87113
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

IntelliCyt Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 27-Jun-2016 $97.3M Completed Generating Revenue
8. Later Stage VC (Series D) 22-Oct-2015 Completed Generating Revenue
7. Debt - General 10-Jun-2014 Completed Generating Revenue
6. Later Stage VC (Series C) 25-Apr-2013 Completed Generating Revenue
5. Secondary Transaction - Private 23-Apr-2010 Completed Product Development
4. Early Stage VC (Series B) 05-Mar-2010 Completed Product Development
3. Grant 31-Dec-2009 Completed Product Development
2. Early Stage VC (Series A1) 09-Oct-2008 $1.5M $2.62M Completed Product Development
1. Early Stage VC (Series A) 31-Dec-2007 $1.12M $1.12M Completed Startup
To view IntelliCyt’s complete valuation and funding history, request access »

IntelliCyt Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D
Series C
Series B
Series A1 3,671,221 $0.000100 $0.02 $0.41 $0.41 1x $0.41 7.32%
Series A 4,256,527 $0.000100 $0.02 $0.26 $0.26 1x $0.26 8.49%
To view IntelliCyt’s complete cap table history, request access »

IntelliCyt Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of cell and bead-based screening for drug discovery. The company develops high-throughput, high-content cell a
Discovery Tools (Healthcare)
Albuquerque, NM
55 As of 2016

Cambridge, United Kingdom
 

Melbourn, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

IntelliCyt Competitors (4)

One of IntelliCyt’s 4 competitors is Sphere Fluidics, a Formerly VC-backed company based in Cambridge, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sphere Fluidics Formerly VC-backed Cambridge, United Kingdom
SPT Labtech Private Equity-Backed Melbourn, United Kingdom
Generative Tensorial Networks Formerly VC-backed London, United Kingdom
Seres Therapeutics Formerly VC-backed Cambridge, MA
To view IntelliCyt’s complete competitors history, request access »

IntelliCyt Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

IntelliCyt Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Arboretum Ventures Venture Capital Minority
Mass Medical Angels Angel Group Minority
New Mexico Community Capital Not-For-Profit Venture Capital Minority
Prolog Ventures Venture Capital Minority
Saba Investments Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

IntelliCyt FAQs

  • When was IntelliCyt founded?

    IntelliCyt was founded in 2006.

  • Where is IntelliCyt headquartered?

    IntelliCyt is headquartered in Albuquerque, NM.

  • What is the size of IntelliCyt?

    IntelliCyt has 55 total employees.

  • What industry is IntelliCyt in?

    IntelliCyt’s primary industry is Discovery Tools (Healthcare).

  • Is IntelliCyt a private or public company?

    IntelliCyt is a Private company.

  • What is the current valuation of IntelliCyt?

    The current valuation of IntelliCyt is .

  • What is IntelliCyt’s current revenue?

    The current revenue for IntelliCyt is .

  • How much funding has IntelliCyt raised over time?

    IntelliCyt has raised $24.4M.

  • Who are IntelliCyt’s investors?

    Arboretum Ventures, Mass Medical Angels, New Mexico Community Capital, Prolog Ventures, and Saba Investments are 5 of 8 investors who have invested in IntelliCyt.

  • Who are IntelliCyt’s competitors?

    Sphere Fluidics, SPT Labtech, Generative Tensorial Networks, and Seres Therapeutics are competitors of IntelliCyt.

  • When was IntelliCyt acquired?

    IntelliCyt was acquired on 27-Jun-2016.

  • Who acquired IntelliCyt?

    IntelliCyt was acquired by Sartorius.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process